Albumin corona on nanoparticles – a strategic approach in drug delivery

References

• Arbós P, Arangoa M, Campanero M, Irache J. (2002). Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles. Int J Pharm 242:129–36
   PubMed Web of Science ®Google Scholar
• Asadishad B, Vossoughi M, Alemzadeh. (2010). Folate-receptor-targeted delivery of doxorubicin using polyethylene glycol-functionalized gold nanoparticles. Ind Eng Chem Res 49:1958–63
   Web of Science ®Google Scholar
• Bardhan M, Mandal G, Ganguly T. (2009). Steady state, time resolved, and circular dichroism spectroscopic studies to reveal the nature of interactions of zinc oxide nanoparticles with transport protein bovine serum albumin and to monitor the possible protein conformational changes. J Appl Phys 106:034701–5
   Web of Science ®Google Scholar
• Bhogale A, Patel N, Mariam J, et al. (2014). Comprehensive studies on the interaction of copper nanoparticles with bovine serum albumin using various spectroscopies. Colloids Surf B Biointerfaces 113:276–84
   PubMed Web of Science ®Google Scholar
• Bhogale A, Patel N, Sarpotdar P, et al. (2013). Systematic investigation on the interaction of bovine serum albumin with ZnO nanoparticles using fluorescence spectroscopy. Colloids Surf B Biointerfaces 102:257–64
   PubMed Web of Science ®Google Scholar
• Borchard G, Kreuter J. (1993). Interaction of serum components with poly(methylmethacrylate) nanoparticles and the resulting body distribution after intravenous injection in rats. J Drug Target 1:15–19
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Joshi P, Shanker V, et al. (2011). Contrasting effect of gold nanoparticles and nanorods with different surface modifications on the structure and activity of bovine serum albumin. Langmuir 27:7722–31
   PubMed Web of Science ®Google Scholar
• Chen RC, Schurr RN, Bhattacharya P, et al. (2012). Interaction of lipid vesicle with silver nanoparticle-serum albumin protein corona. Appl Phys Lett 100:013703-1–4
   Web of Science ®Google Scholar
• Churchman AH, Wallace R, Milne SJ, et al. (2013). Serum albumin enhances the membrane activity of ZnO nanoparticles. Chem Commun 49:4172–4
   PubMed Web of Science ®Google Scholar
• Cifuentes-Rius A, de Puig H, Kah JCY, et al. (2013). Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release. ACS Nano 7:10066–74
   PubMed Web of Science ®Google Scholar
• De Paoli SH, Diduch LL, Tegegn TZ, et al. (2014). The effect of protein corona composition on the interaction of carbon nanotubes with human blood platelets. Biomaterials 35:6182–94
   PubMed Web of Science ®Google Scholar
• Desai N, Abraxis BioScience Inc. (2007). Nanoparticle albumin bound (nab) technology:targeting tumors through the endothelial gp60 receptor and SPARC. Nanomedicine 3:337–46
   Web of Science ®Google Scholar
• Dieni C, Stone C, Armstrong M, et al. (2013). Spherical gold nanoparticles impede the function of bovine serum albumin in vitro: a new consideration for studies in nanotoxicology. J Nanomater Mol Nanotechnol 2:6. doi:10.4172/2324-8777.1000124
   Google Scholar
• Dobrovolskaia MA, Patri AK, Zheng J, et al. (2009). Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 5:106–17
   PubMed Web of Science ®Google Scholar
• Fleischer C, Payne C. (2014). Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes. Acc Chem Res 47:2651–9
   PubMed Web of Science ®Google Scholar
• Gao D, Tian Y, Bi S, et al. (2005). Studies on the interaction of colloidal gold and serum albumins by spectral methods. Spectrochim Acta A 62:1203–8
   PubMed Web of Science ®Google Scholar
• Gao D, Tian Y, Liang F, et al. (2006). Investigation on the interaction between colloidal gold and human complement factor 4 at different pH by spectral methods. Colloid Surf B 47:71–7
   PubMed Web of Science ®Google Scholar
• Gao X, Liu Z, Lin Z, Su X. (2014). CuInS2 quantum dots/poly(L-glutamic acid)–drug conjugates for drug delivery and cell imaging. Analyst 139:831–6
   PubMed Web of Science ®Google Scholar
• Garza-Ocañas L, Ferrer DA, Burt J, et al. (2010). Biodistribution and long-term fate of silver nanoparticles functionalized with bovine serum albumin in rats. Metallomics 2:204–10
   PubMed Web of Science ®Google Scholar
• Gaur KP, Mishra S, Bajpai M, Mishra A. (2014). Enhanced oral bioavailability of efavirenz by solid lipid nanoparticles: in vitro drug release and pharmacokinetics studies. Biomed Res Int 2014:363404
   PubMed Web of Science ®Google Scholar
• Goy-López S, Juárez J, Alatorre-Meda M, et al. (2012). Physicochemical characteristics of protein–NP bioconjugates: the role of particle curvature and solution conditions on human serum albumin conformation and fibrillogenesis inhibition. Langmuir 28:9113–26
   PubMed Web of Science ®Google Scholar
• Jhonsi M, Kathiravan A, Renganathan R. (2009). Spectroscopic studies on the interaction of colloidal capped CdS nanoparticles with bovine serum albumin. Colloid Surf B 72:167–72
   PubMed Web of Science ®Google Scholar
• Joshi P, Chakraborty S, Dey S, et al. (2011). Binding of chloroquine-conjugated gold nanoparticles with bovine serum albumin. J Colloid Interface Sci 355:402–9
   PubMed Web of Science ®Google Scholar
• Jung B, Anvari B. (2012). Synthesis and characterization of bovine serum albumin-coated nanocapsules loaded with indocyanine green as potential multifunctional nanoconstructs. Biotechnol Prog 28:533–9
   PubMed Web of Science ®Google Scholar
• Jung SK, Kim SK, Jung SH, et al. (2010). Increased stability in plasma and enhanced cellular uptake of thermally denatured albumin-coated liposomes. Colloids Surf B Biointerfaces 76:434–40
   PubMed Web of Science ®Google Scholar
• Kathiravan A, Anandan S, Renganathan R. (2009a). Interaction of colloidal TiO2 with human serum albumin: a fluorescence quenching study. Colloid Surf A 333:91–5
   Web of Science ®Google Scholar
• Kathiravan A, Renganathan R, Anandan S. (2009b). Interaction of colloidal AgTiO2 nanoparticles with bovine serum albumin. Polyhedron 28:157–61
   Web of Science ®Google Scholar
• Kathiravan A, Renganathan R. (2008). Interaction of colloidal TiO2 with bovine serum albumin. Colloid Surf A 324:176–80
   Web of Science ®Google Scholar
• Khullar P, Singh V, Mahal A, et al. (2012). Bovine serum albumin bioconjugated gold nanoparticles: synthesis, hemolysis and cytotoxicity toward cancer cell lines. J Phys Chem C 116:8834–43
   Web of Science ®Google Scholar
• Kong L, Hu J, Qin D, Yan P. (2015). Interaction of ifosfamide-loaded superparamagnetic iron oxide nanoparticles with human serum albumin – a biophysical study. J Pharm Innov 10:13–20
   Web of Science ®Google Scholar
• Koo O, Rubinstein I, Onyuksel H. (2005). Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine 1:193–212
   PubMed Web of Science ®Google Scholar
• Kummitha CM, Malamas AS, Lu Z. (2012). Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles. Int J Nanomed 7:5205–14
   PubMed Web of Science ®Google Scholar
• Landry F, Bazile D, Spenlehauer G, et al. (1998). Peroral administration of 14C-poly(D,L-lactic acid) nanoparticles coated with human serum albumin or polyvinyl alcohol to guinea pigs. J Drug Target 6:293–307
   PubMed Web of Science ®Google Scholar
• Landry FB, Bazile DV, Spenlehauer VM. (1996). Degradation of poly(d,l-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII). Biomaterials 17:715–23
   PubMed Web of Science ®Google Scholar
• Li C, Xing L, Che S. (2012). Coordination bonding based pH-responsive albumin nanoparticles for anticancer drug delivery. Dalton Trans 41:3714–19
   PubMed Web of Science ®Google Scholar
• Liu Y, Ji F, Liu R. (2013). The interaction of bovine serum albumin with doxorubicin-loaded superparamagnetic iron oxide nanoparticles: spectroscope and molecular modelling identification. Nanotoxicology 7:97–104
   PubMed Web of Science ®Google Scholar
• Lu W, Wan J, She Z, Jiang X. (2007). Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. J Control Release 118:38–53
   PubMed Web of Science ®Google Scholar
• Lu W, Zhang Y, Tan Y, et al. (2005). Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Release 107:428–48
   PubMed Web of Science ®Google Scholar
• Ma Z, Bai J, Wang Y, Jiang X. (2014). Impact of shape and pore size of mesoporous silica nanoparticles on serum protein adsorption and RBCs hemolysis. ACS Appl Mater Interfaces 6:2431–8
   PubMed Web of Science ®Google Scholar
• Maffre P, Brandholt S, Nienhaus K, et al. (2014). Effects of surface functionalization on the adsorption of human serum albumin onto nanoparticles – a fluorescence correlation spectroscopy study. Beilstein J Nanotechnol 5:2036–47
   PubMed Web of Science ®Google Scholar
• Mariam J, Dongre P, Kothari D. (2011). Study of interaction of silver nanoparticles with bovine serum albumin using fluorescence spectroscopy. J Fluoresc 21:2193–9
   PubMed Web of Science ®Google Scholar
• Mariam J, Sivakami S, Kothari D, Dongre P. (2014). Bioactivity of albumins bound to silver nanoparticles. Protein J 33:258–66
   PubMed Web of Science ®Google Scholar
• Marucco A, Fenoglio I, Turci F, Fubini B. (2013). Interaction of fibrinogen and albumin with titanium dioxide nanoparticles of different crystalline phases. J Phys Conf Ser 429:012014
   Google Scholar
• Monopoli MP, Aberg C, Salvati A, Dawson KA. (2012). Biomolecular coronas provide the biological identity of nanosized materials. Nat Nano 7:779–86
   PubMed Web of Science ®Google Scholar
• Mortimer GM, Butcher NJ, Musumeci AW, et al. (2014). Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials. ACS Nano 8:3357–66
   PubMed Web of Science ®Google Scholar
• Nigam P, Waghmode S, Louis M, et al. (2014). Graphene quantum dots conjugated albumin nanoparticles for targeted drug delivery and imaging of pancreatic cancer. J Mater Chem B 2:3190–5
   PubMed Web of Science ®Google Scholar
• Pan B, Cui D, Xu P, et al. (2007). Study on interaction between gold nanorod and bovine serum albumin. Colloid Surf A 295:217–22
   Web of Science ®Google Scholar
• Pan B, Gao F, Ao L. (2005). Investigation of interactions between dendrimer-coated magnetite nanoparticles and bovine serum albumin. J Magn Magn Mater 293:252–8
   Web of Science ®Google Scholar
• Peng Q, Wei X, Shao X, et al. (2014). Nanocomplex based on biocompatible phospholipids and albumin for long-circulation applications. ACS Appl Mater Interfaces 6:13730–7
   PubMed Web of Science ®Google Scholar
• Peng Q, Zhang S, Yang Q, et al. (2013). Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. Biomaterials 34:8521–30
   PubMed Web of Science ®Google Scholar
• Peters T. (1996). All about albumin:biochemistry, genetics and medical applications. San Diego: Academic Press
   Google Scholar
• Pramanik S, Banerjee P, Sarkar A, Bhattacharya SC. (2008). Size-dependent interaction of gold nanoparticles with transport protein: a spectroscopic study. J Lumin 128:1969–74
   Web of Science ®Google Scholar
• Qi J, Yao P, He F, et al. (2010). Nanoparticles with dextran/chitosan shell and BSA/chitosan core – doxorubicin loading and delivery. Int J Pharm 393:176–84
   PubMed Web of Science ®Google Scholar
• Quan Q, Xie J, Gao H, et al. (2011). HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy. Mol Pharm 8:1669–76
   PubMed Web of Science ®Google Scholar
• Ramezani F, Amanlou M, Rafii-Tabar H. (2014). Gold nanoparticle shape effects on human serum albumin corona interface: a molecular dynamic study. J Nanopart Res doi: 10.1007/s11051-014-2512-1
   Web of Science ®Google Scholar
• Rastogi L, Kora A, Arunachalam J. (2012). Highly stable, protein capped gold nanoparticles as effective drug delivery vehicles for amino-glycosidic antibiotics. Mater Sci Eng C Mater Bio Appl 32:1571–7
   PubMed Web of Science ®Google Scholar
• Ravindran A, Singh A, Raichur A, et al. (2010). Studies on interaction of colloidal Ag nanoparticles with bovine serum albumin (BSA). Colloid Surf B 76:32–7
   PubMed Web of Science ®Google Scholar
• Salvati A, Aberg C, dos Santos T, et al. (2011). Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomedicine 7:818–26
   PubMed Web of Science ®Google Scholar
• Samsonova YS, Priezzhev AV, Lugovtsov AE, et al. (2012). Investigation of interaction of albumin molecules with diamond nanoparticles in aqueous solutions by dynamic light scattering. Quantum Electron 42:484–488
   Web of Science ®Google Scholar
• Shang L, Wang Y, Jiang J, Dong S. (2007). pH dependent protein conformational change in albumin: gold nanoparticle bioconjugates: a spectroscopic study. Langmuir 23:2714–21
   PubMed Web of Science ®Google Scholar
• Singh AV, Bandgar BM, Kasture M, et al. (2005). Synthesis of gold, silver and their alloy nanoparticles using bovine serum albumin as foaming and stabilizing agent. J Mater Chem 15:5115–21
   Web of Science ®Google Scholar
• Sripriyalakshmi S, Anjali CH, Doss G, et al. (2014). BSA nanoparticle loaded atorvastatin calcium – a new facet for an old drug. Plos One 9:1–10
   Web of Science ®Google Scholar
• Tao X, Zhang Q, Ling K, et al. (2012). Effect of pullulan nanoparticle surface charges on HSA complexation and drug release behavior of HSA-bound nanoparticles. PLos One 7:e49304
   PubMed Web of Science ®Google Scholar
• Vauthier C, Lindner P, Cabane B. (2009). Configuration of bovine serum albumin adsorbed on polymer particles with grafted dextran corona. Colloids Surf B Biointerfaces 69:207–15
   PubMed Web of Science ®Google Scholar
• Vroman L, Adams A, Fischer G, Munoz P. (1980). Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plamsa at interfaces. Blood 55:156–9
   PubMed Web of Science ®Google Scholar
• Vishnu P, Roy V. (2011). Safety and efficacy of nab-paclitaxel in the treatment of patients with breast cancer. Breast Cancer 5:53–65
   PubMedGoogle Scholar
• Weecharangsan W, Yu B, Zheng Y, et al. (2009). Efficient delivery of antisense oligodeoxyribonucleotide G3139 by human serum albumin-coated liposomes. Mol Pharm 6:1848–55
   PubMed Web of Science ®Google Scholar
• Xia B, Zhang W, Shi J, Xiao S. (2013). Engineered stealth porous silicon nanoparticles via surface encapsulation of bovine serum albumin for prolonging blood circulation in vivo. ACS Appl Mater Interfaces 5:11718–24
   PubMed Web of Science ®Google Scholar
• Yang Q, Liang J, Han H. (2009). Probing the interaction of magnetic iron oxide nanoparticles with bovine serum albumin by spectroscopic techniques. J Phys Chem B 113:10454–8
   PubMed Web of Science ®Google Scholar
• Zaloga J, Janko C, Nowak J, et al. (2014). Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility. Int J Nanomed 9:4847–66
   PubMed Web of Science ®Google Scholar
• Zhang C, Cao J, Yin D, et al. (2004). Preparation and radiolabeling of human serum albumin (HSA)-coated magnetite nanoparticles for magnetically targeted therapy. Appl Radiat Isot 61:1255–9
   PubMed Web of Science ®Google Scholar